399 In HR+/HER2+ breast cancer, there is potential for endocrine therapy to replace chemotherapy in combination with anti-HER2 drugs
2018;16: e2006203
Bispecific molecules are more often designed to target antigens expressed on the same cell or cells within the same environment but our data also demonstrates the feasibility of achieving dual pharmacology when targeting molecules in very different compartments: a soluble serum protein (PCSK9) and a GPCR predominately expressed in pancreatic -cells (GLP-1R)
Refrigerate at 2C8C, keep the vial sealed and away from light, and do not freeze it
Micro BCA Protein Assay Kit, H 2 DCFDA (H 2 -DCF, DCF), C11-BODIPY (581/591), MitoSOX Red Mitochondrial Superoxide Indicator, MitoTracker Red CMXRos, and Dulbeccos modified Eagles medium (High glucose, no glutamine, no methionine, no Cys 2 ) were purchased from Thermo Scientific (Waltham, MA, USA)